Skip to main content
OpenTrials
Completed

NCT Number: NCT03022383

TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus

To determine optimal cut-off value for the TopQ cut-off on the DRI OCT Triton plus

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Eyes

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Topcon Medical Systems Inc.

Oakland, New Jersey, 07436, United States

About this study

Scans with a TopQ score below the optimum cut-off should be considered to be poor or unacceptable quality, and scans with a TopQ score above the cut-off should be considered good or acceptable quality. The study will evaluate the predetermined cut-off values by investigating measurement variability of scans.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must be at least 18 years of age
  • Participants must be able to complete all testing (all OCT scans)
  • Participants must volunteer to be in the study and sign the consent form

Exclusion criteria

  • Subject with history of ocular disease or ocular pathology

Treatment and study plan

DRI OCT Triton plus

Device

OCT Machine used for diagnostic purposes

Primary outcomes

  1. Measurement Variability of Signal to Noise Ratio

    Time frame: 1 hour

Sponsors and collaborators

Lead sponsor

Topcon Medical Systems, Inc.

Industry

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Jan 16, 2017
Registry last updated
Jun 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.